Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -80,728 | -206,891 | -179,547 | -127,745 | -50,087 |
| Depreciation Amortization | 6,321 | 25,868 | 18,993 | 13,059 | 6,250 |
| Accounts receivable | 18,824 | -42,328 | -22,019 | 1,927 | -3,184 |
| Accounts payable and accrued liabilities | -6,227 | 9,158 | 934 | 2,067 | 49 |
| Other Working Capital | -6,610 | 123,054 | 118,592 | -25,525 | -24,617 |
| Other Operating Activity | 612 | 68,664 | 44,859 | 16,527 | 10,881 |
| Operating Cash Flow | $-67,808 | $-22,475 | $-18,188 | $-119,690 | $-60,708 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,133 | -32,417 | -25,229 | -18,232 | -7,453 |
| Purchase Of Investment | -28,115 | -507,912 | -173,334 | -93,942 | -37,243 |
| Sale Of Investment | 241,014 | 320,634 | 266,303 | 163,292 | 86,984 |
| Other Investing Activity | -1,101 | 11,224 | 4,090 | 0 | 0 |
| Investing Cash Flow | $205,665 | $-208,471 | $71,830 | $51,118 | $42,288 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,393 | 366,035 | 351,733 | 31,927 | 22,321 |
| Other Financing Activity | -49 | -170 | -170 | -218 | -161 |
| Financing Cash Flow | $3,344 | $365,865 | $351,563 | $31,709 | $22,160 |
| Exchange Rate Effect | -44 | 207 | 181 | 248 | 42 |
| Beginning Cash Position | 213,171 | 78,045 | 78,045 | 78,045 | 78,045 |
| End Cash Position | 354,328 | 213,171 | 483,431 | 41,430 | 81,827 |
| Net Cash Flow | $141,157 | $135,126 | $405,386 | $-36,615 | $3,782 |
| Free Cash Flow | |||||
| Operating Cash Flow | -67,808 | -22,475 | -18,188 | -119,690 | -60,708 |
| Capital Expenditure | -6,133 | -32,417 | -25,229 | -18,232 | -7,453 |
| Free Cash Flow | -73,941 | -54,892 | -43,417 | -137,922 | -68,161 |